Streetbeat News

Insider Trading

BKYI

BIO-Key International's Chief Legal Officer, James David Sullivan, purchased 39,671 shares at an average price of $0.18 per share, according to a Form 4 filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 6:43 pm

MODG

PRGO

XRAY

Insider purchases were made in three companies: Perrigo Company plc, DENTSPLY SIRONA Inc., and Topgolf Callaway Brands Corp. Perrigo's EVP and CHRO bought shares after better-than-expected Q3 earnings. DENTSPLY SIRONA's Director made purchases following the announcement of a $1 billion share repurchase program. Topgolf Callaway's President and CEO acquired shares despite mixed Q3 results and lowered FY23 guidance. Insider buying can indicate confidence in the company's prospects or undervaluation.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 1:44 pm

AOS

HIBB

HRB

Insiders at H&R Block, United States Steel, Hibbett, and A. O. Smith have recently sold shares of their companies. H&R Block's CFO sold shares worth $2.21 million, United States Steel's SVP sold shares worth $175,000, Hibbett's SVP and CIO sold shares worth $129,470, and A. O. Smith's Director sold shares worth $205,227. These sales occurred after each company reported strong quarterly results. Insider sales can indicate various sentiments and should not be the sole basis for investment decisions.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 12:42 pm

ROI

Milton Ault, a 10%+ owner of RiskOn International, reported the purchase of 2,133 shares at an average price of $0.39 per share in a Form 4 filing on Monday.

Portfolio Pulse from Charles Gross

November 28, 2023 | 11:41 am

AIM

BBGI

ICU

ROI

Insiders at four US-listed companies have recently made notable purchases of their own company's stock. SeaStar Medical Holding Corporation (ICU) Director Kenneth Heel Van bought 100,000 shares. Beasley Broadcast Group, Inc. (BBGI) CEO Caroline Beasley acquired 2,712 shares. RiskOn International, Inc. (ROI) 10% owner Milton C. Ault III purchased 2,133 shares. AIM ImmunoTech Inc. (AIM) CEO and President Thomas K Equels bought 33,861 shares. These transactions occurred despite recent financial setbacks for these companies, such as posting wider-than-expected quarterly losses or experiencing significant stock price declines.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 11:39 am

PUYI

Puyi Inc. (NASDAQ:PUYI), a wealth management services provider in China, has appointed Ms. Yang Yuanfen as the new CFO, effective immediately. She replaces Mr. Hu Anlin, who resigned from his position as CFO, Vice President, and director of the company.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 10:02 am

AORT

Sen. Tina Smith's spouse made a profit of up to $55K in nearly 3 weeks from trading shares of Artivion, Inc. (AORT), a medical device company. The stock was purchased on Nov. 10 and Nov. 16, before rallying 31.16% to $17.51 by the end of the monitored period. Artivion's stock has lost 40% over the last five years, but recent Q3 results showed improved revenue and earnings, contributing to the stock's rise. Smith's trades have drawn criticism, especially in light of her previous comments on corporate executive compensation.

Portfolio Pulse from Shanthi Rexaline

November 28, 2023 | 8:38 am

PGY

PLSE

Pagaya Technologies shares are down due to a CFO transition. Pulse Biosciences shares are up after receiving regulatory approvals for a feasibility study and news of potential stock purchases by Executive Chairman Robert W. Duggan.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 8:01 pm

PLSE

Pulse Biosciences, Inc. has announced receiving all necessary regulatory approvals and completing required activities to begin its catheter ablation feasibility study. Additionally, Executive Chairman Robert W. Duggan is considering purchasing more shares of the company's common stock.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 7:55 pm

THC

VRSN

Insiders at VeriSign, Tenet Healthcare, Goldman Sachs, and Dycom Industries have recently sold shares. VeriSign's CEO sold shares after reporting lower-than-expected revenue. Tenet Healthcare's director sold shares following an agreement to sell hospitals for $2.4 billion. Goldman Sachs' CAO sold shares amidst news of the Japan President stepping down. Dycom Industries' CAO sold shares after reporting strong financial results. Insider sales can indicate various sentiments about the company's prospects and stock valuation.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 1:27 pm